Radius Health Company Profile (NASDAQ:RDUS)

About Radius Health

Radius Health logoRadius Health, Inc. is a biopharmaceutical company focused on developing therapeutics in the areas of osteoporosis, oncology and endocrine diseases. Its product candidate, the investigational drug abaloparatide for subcutaneous injection, has completed Phase III development for use in the reduction of fracture risk in postmenopausal women with osteoporosis. Its clinical pipeline also includes an investigational abaloparatide transdermal patch for use in osteoporosis and the investigational drug RAD1901 for use in hormone-driven and hormone-resistant breast cancer, and vasomotor symptoms in postmenopausal women. Its preclinical pipeline includes RAD140, a non-steroidal, selective androgen receptor modulator (SARM) under investigation for use in cancer.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: RDUS
  • CUSIP:
Key Metrics:
  • Previous Close: $43.81
  • 50 Day Moving Average: $43.48
  • 200 Day Moving Average: $48.71
  • 52-Week Range: $24.76 - $59.88
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -12.42
  • P/E Growth: -3.41
  • Market Cap: $1.83B
  • Outstanding Shares: 43,111,000
  • Beta: 1.54
Profitability:
  • Return on Equity: -40.09%
  • Return on Assets: -38.09%
Debt:
  • Current Ratio: 14.76%
  • Quick Ratio: 14.76%
Additional Links:
Companies Related to Radius Health:

Analyst Ratings

Consensus Ratings for Radius Health (NASDAQ:RDUS) (?)
Ratings Breakdown: 1 Sell Rating, 2 Hold Ratings, 5 Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $57.57 (35.53% upside)

Analysts' Ratings History for Radius Health (NASDAQ:RDUS)
Show:
DateFirmActionRatingPrice TargetDetails
12/21/2016Canaccord GenuityReiterated RatingBuy$85.00View Rating Details
12/8/2016Cantor FitzgeraldSet Price TargetBuy$70.00View Rating Details
9/28/2016Cowen and CompanyReiterated RatingBuyView Rating Details
9/21/2016HC WainwrightBoost Price TargetBuy$55.00 -> $71.00View Rating Details
9/20/2016Jefferies Group LLCReiterated RatingHold$46.00View Rating Details
8/5/2016J P Morgan Chase & CoReiterated RatingBuy$70.00View Rating Details
8/4/2016Maxim GroupDowngradeHold -> Sell$24.00View Rating Details
3/30/2016Goldman Sachs Group, Inc. (The)Initiated CoverageNeutral$37.00View Rating Details
1/25/2016Bank of America CorpReiterated RatingBuy$89.00View Rating Details
8/14/2015Deutsche Bank AGInitiated CoverageBuy$90.00View Rating Details
(Data available from 2/23/2015 forward)

Earnings

Earnings History for Radius Health (NASDAQ:RDUS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/23/2017        
2/23/2017Q416($1.34)N/AView Earnings Details
11/3/2016Q316($1.03)($1.07)ViewN/AView Earnings Details
8/4/2016Q216($0.95)($1.01)ViewN/AView Earnings Details
5/5/2016Q116($0.74)($0.94)ViewN/AView Earnings Details
2/25/2016Q415($0.64)($0.77)ViewListenView Earnings Details
11/5/2015Q315($0.58)($0.68)ViewN/AView Earnings Details
8/6/2015Q215($0.52)($0.61)ViewN/AView Earnings Details
5/6/2015Q115($0.52)($0.47)ViewN/AView Earnings Details
3/10/2015Q414($0.63)($0.55)ViewN/AView Earnings Details
11/10/2014Q314($0.65)($0.59)ViewN/AView Earnings Details
8/12/2014Q2($0.89)($2.22)$16.24 million$10.62 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Radius Health (NASDAQ:RDUS)
Current Year EPS Consensus Estimate: $-4.41 EPS
Next Year EPS Consensus Estimate: $-3.42 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.80)($0.79)($0.80)
Q2 20161($0.99)($0.99)($0.99)
Q3 20161($1.05)($1.05)($1.05)
Q4 20161($1.12)($1.12)($1.12)
Q1 20171($0.94)($0.94)($0.94)
Q2 20171($1.18)($1.18)($1.18)
Q3 20171($1.16)($1.16)($1.16)
Q4 20171($1.02)($1.02)($1.02)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Radius Health (NASDAQ:RDUS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Radius Health (NASDAQ:RDUS)
Insider Ownership Percentage: 16.80%
Institutional Ownership Percentage: 95.84%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/22/2016Growth N V BiotechMajor ShareholderBuy38,259$31.67$1,211,662.53View SEC Filing  
1/13/2016Growth N V BiotechMajor ShareholderBuy50,000$39.90$1,995,000.00View SEC Filing  
11/12/2015Gary HattersleyinsiderSell5,683$75.00$426,225.00View SEC Filing  
11/3/2015Gary HattersleyinsiderSell13,333$70.00$933,310.00View SEC Filing  
10/23/2015Gary HattersleyinsiderSell11,302$65.00$734,630.00View SEC Filing  
10/21/2015Gary HattersleyinsiderSell1,501$65.36$98,105.36View SEC Filing  
10/21/2015Rob WardCEOSell50,000$61.99$3,099,500.00View SEC Filing  
8/21/2015Growth N. V. Biotechmajor shareholderBuy100,000$64.00$6,400,000.00View SEC Filing  
8/17/2015Kurt GravesDirectorSell22,694$70.00$1,588,580.00View SEC Filing  
7/6/2015Kurt GravesDirectorSell25,000$69.48$1,737,000.00View SEC Filing  
6/18/2015Kurt GravesDirectorSell25,000$55.05$1,376,250.00View SEC Filing  
5/1/2015Growth N V BiotechMajor ShareholderBuy50,000$36.46$1,823,000.00View SEC Filing  
4/29/2015Growth N V BiotechMajor ShareholderBuy50,000$36.23$1,811,500.00View SEC Filing  
4/28/2015Growth N V BiotechMajor ShareholderBuy50,000$36.59$1,829,500.00View SEC Filing  
4/27/2015Growth N V BiotechMajor ShareholderBuy50,000$38.38$1,919,000.00View SEC Filing  
3/6/2015Growth N V BiotechMajor ShareholderBuy75,000$47.08$3,531,000.00View SEC Filing  
2/25/2015Growth N V BiotechMajor ShareholderBuy35,000$45.74$1,600,900.00View SEC Filing  
6/11/2014Morana Jovan-EmbiricosDirectorBuy587,500$8.00$4,700,000.00View SEC Filing  
6/6/2014Growth N V BiotechMajor ShareholderBuy1,000,000$8.00$8,000,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Radius Health (NASDAQ:RDUS)
DateHeadline
biz.yahoo.com logoQ4 2016 Radius Health Inc Earnings Release - Time Not Supplied (NASDAQ:RDUS)
biz.yahoo.com - February 23 at 8:35 AM
News IconStock Review: Level Check for Radius Health, Inc. (NASDAQ:RDUS) - Searcy News (NASDAQ:RDUS)
searcysentinel.com - February 22 at 7:37 PM
News IconRadius Health, Inc. (NASDAQ:RDUS) Daily Sentiment Score At 0.477 - Stock Observer (NASDAQ:RDUS)
www.thestockobserver.com - February 22 at 7:37 PM
News IconRadius Health, Inc. (NASDAQ:RDUS) Quarterly EPS At $-1.02 - Stock Observer (NASDAQ:RDUS)
www.thestockobserver.com - February 19 at 6:30 PM
News IconNumbers in Review for Radius Health Inc. (RDUS) - Midway Monitor (NASDAQ:RDUS)
midwaymonitor.com - February 18 at 8:16 AM
News IconRadius Health Inc RDUS Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:RDUS)
www.bioportfolio.com - February 16 at 7:08 PM
News IconRadius Health, Inc. (NASDAQ:RDUS) Daily Sentiment Score At 0.361 - Stock Observer (NASDAQ:RDUS)
www.thestockobserver.com - February 15 at 12:32 AM
News IconNumbers in Review for Radius Health Inc. (RDUS) - Piedmont Register (NASDAQ:RDUS)
piedmontregister.com - February 10 at 10:22 PM
News IconRadius Health, Inc. (NASDAQ:RDUS) Daily Sentiment Score At 0.623 - Stock Observer (NASDAQ:RDUS)
www.thestockobserver.com - February 7 at 10:53 PM
realistinvestor.com logoRadius Health, Inc. (NASDAQ:RDUS) EPS Projection At $-0.7 - RealistInvestor.com (NASDAQ:RDUS)
www.realistinvestor.com - February 6 at 12:19 AM
News IconRadius Health INC (RDUS) Holder Mpm Asset Management LLC Decreased Stake by $104.96 Million as Stock Price Rose (NASDAQ:RDUS)
randolphguide.com - February 4 at 3:17 AM
streetinsider.com logoRadius Health (RDUS) Says Positive Results from 6-month Interim Analysis of ACTIVExtend Trial Were Published in ... - StreetInsider.com (NASDAQ:RDUS)
www.streetinsider.com - February 3 at 10:15 PM
streetinsider.com logoRadius Health (RDUS) Says Positive Results from 6-month Interim Analysis of ACTIVExtend Trial Were Published in Mayo Clinic Proceedings (NASDAQ:RDUS)
www.streetinsider.com - February 1 at 10:51 PM
finance.yahoo.com logo8:29 am Radius Health announces that positive results from a planned 6-month interim analysis of the ACTIVExtend clinical trial were published in the Mayo Clinic Proceedings (NASDAQ:RDUS)
finance.yahoo.com - February 1 at 10:51 PM
finance.yahoo.com logoMayo Clinic Proceedings Publishes Positive Results from the ACTIVExtend Clinical Trial of Abaloparatide-SC in Postmenopausal Women With Osteoporosis (NASDAQ:RDUS)
finance.yahoo.com - February 1 at 10:51 PM
News IconFirms & Funds Maintain Significant Positions In Radius Health, Inc. (NASDAQ:RDUS) - Wall Street Beacon (NASDAQ:RDUS)
wsbeacon.com - February 1 at 6:35 AM
News IconTrading Circle: Narrowing in on Shares of Radius Health, Inc. (NASDAQ:RDUS) - The Tribune (NASDAQ:RDUS)
lakecitytribune.com - January 30 at 8:02 AM
News IconQuarterly EPS Of Radius Health, Inc. (NASDAQ:RDUS) Set At $-0.7 - Stock Observer (NASDAQ:RDUS)
www.thestockobserver.com - January 29 at 8:32 AM
News IconTrading Indicator Check on Radius Health Inc. (RDUS) - Springdale Times (NASDAQ:RDUS)
springdaletimes.com - January 29 at 12:38 AM
News IconRadius Health, Inc. (NASDAQ:RDUS) Bearish Target At $78 | Stock ... - Stock Observer (NASDAQ:RDUS)
www.thestockobserver.com - January 28 at 6:05 AM
News IconFree Cash Flow Score in Focus for Radius Health, Inc. (NASDAQ:RDUS) - The Tribune (NASDAQ:RDUS)
lakecitytribune.com - January 28 at 6:05 AM
News IconInteresting RDUS Put And Call Options For March 17th (NASDAQ:RDUS)
www.stockoptionschannel.com - January 26 at 2:47 AM
News IconChecking the Levels on Shares of Radius Health, Inc. (NASDAQ:RDUS) - The Tribune (NASDAQ:RDUS)
lakecitytribune.com - January 24 at 9:06 PM
News IconKeeping Tabs on Technicals for Radius Health Inc. (RDUS) - Springdale Times (NASDAQ:RDUS)
springdaletimes.com - January 24 at 9:06 PM
News IconRadius Health, Inc. (NASDAQ:RDUS) Daily Sentiment Score At 0.56 - Stock Observer (NASDAQ:RDUS)
www.thestockobserver.com - January 24 at 9:06 PM
News IconVolatility Spiking as Shares Ride the Wave: Radius Health, Inc. (NASDAQ:RDUS) - Wall Street Beacon (NASDAQ:RDUS)
wsbeacon.com - January 24 at 9:06 PM
News IconPriming The Pump: Stock Volatility Spotted in Radius Health, Inc. (NASDAQ:RDUS) - Wall Street Beacon (NASDAQ:RDUS)
wsbeacon.com - January 23 at 7:48 PM
News IconWhat are the Technical Charts Saying About Radius Health Inc. (RDUS) - Rives Journal (NASDAQ:RDUS)
rivesjournal.com - January 23 at 9:10 AM
News IconGearing Up For a Bull Run? Analysts Weigh in on Radius Health, Inc. (NASDAQ:RDUS) - Wall Street Beacon (NASDAQ:RDUS)
wsbeacon.com - January 18 at 8:09 AM
News IconChecking Indicator Levels for Radius Health Inc. (RDUS) - Springdale Times (NASDAQ:RDUS)
springdaletimes.com - January 17 at 12:40 PM
News IconRunning on Fumes? Stock Sluggish Out of the Gate: Radius Health, Inc. (NASDAQ:RDUS) - Aiken Advocate (NASDAQ:RDUS)
aikenadvocate.com - January 17 at 12:40 PM
realistinvestor.com logoRadius Health, Inc. (NASDAQ:RDUS) EPS Estimate At $-0.7 - RealistInvestor.com (NASDAQ:RDUS)
www.realistinvestor.com - January 16 at 1:20 PM
News IconHow Does the Chart Look for Radius Health, Inc. (RDUS) ? - The USA Commerce (NASDAQ:RDUS)
theusacommerce.com - January 16 at 1:20 PM
News IconStock Reaching Most Volatile List Today: Radius Health, Inc. (NASDAQ:RDUS) - Wall Street Beacon (NASDAQ:RDUS)
wsbeacon.com - January 12 at 1:13 AM
News IconRadius Health, Inc. (NASDAQ:RDUS) Daily Sentiment Score At 0.435 - Stock Observer (NASDAQ:RDUS)
www.thestockobserver.com - January 11 at 2:17 AM
News IconRadius Health, Inc. (NASDAQ:RDUS) shows weekly volitility of 6.46% - The Newburgh Press (NASDAQ:RDUS)
newburghpress.com - January 11 at 2:17 AM
seekingalpha.com logoRadius Health (RDUS) presents at 35th Annual J.P. Morgan Healthcare Conference (NASDAQ:RDUS)
seekingalpha.com - January 10 at 9:16 PM
realistinvestor.com logoRadius Health, Inc. (NASDAQ:RDUS) Is Expected To Post EPS Of $-0.7 - RealistInvestor.com (NASDAQ:RDUS)
www.realistinvestor.com - January 9 at 7:09 AM
News IconBearish Target Of Radius Health, Inc. (NASDAQ:RDUS) At $78 - Stock Observer (NASDAQ:RDUS)
www.thestockobserver.com - January 6 at 8:19 PM
finance.yahoo.com logoRadius Health to Present at the 35th Annual J.P. Morgan Healthcare Conference (NASDAQ:RDUS)
finance.yahoo.com - January 6 at 8:19 PM
News IconDaily Sentiment Score Of Radius Health, Inc. (NASDAQ:RDUS) At 0.539 - Stock Observer (NASDAQ:RDUS)
www.thestockobserver.com - January 5 at 1:48 AM
nasdaq.com logoRadius Health Enters Oversold Territory (RDUS) (NASDAQ:RDUS)
www.nasdaq.com - January 4 at 12:18 AM
News IconQuarterly EPS Of Radius Health, Inc. (NASDAQ:RDUS) At $-0.7 - Stock Observer (NASDAQ:RDUS)
www.thestockobserver.com - January 1 at 8:48 AM
News IconDaily Sentiment Score Of Radius Health, Inc. (NASDAQ:RDUS) At 0.435 - Stock Observer (NASDAQ:RDUS)
www.thestockobserver.com - December 27 at 3:34 PM
News IconUpside Alert: Delving into Shares of Radius Health, Inc. (NASDAQ:RDUS) - Prospect Journal (NASDAQ:RDUS)
prospectjournal.com - December 27 at 9:30 AM
News IconRadius Health, Inc. (NASDAQ:RDUS) Daily Sentiment Score At 0.56 ... - Stock Observer (NASDAQ:RDUS)
www.thestockobserver.com - December 20 at 2:08 PM
News IconChecking the Levels on Shares of Radius Health, Inc. (NASDAQ:RDUS) - The Business Journal (NASDAQ:RDUS)
belmontbusinessjournal.com - December 20 at 2:08 PM
News IconSorting Out the Technicals on Shares of Radius Health Inc. (RDUS) - Yankee Analysts (NASDAQ:RDUS)
yankeeanalysts.com - December 18 at 7:51 PM
forbes.com logoAnalysts Forecast 16% Upside For IYH (NASDAQ:RDUS)
www.forbes.com - December 16 at 9:04 PM
smarteranalyst.com logoCanaccord Chimes in on Radius Health Inc (RDUS) Following Promising Phase 3 Data in Breast Cancer (NASDAQ:RDUS)
www.smarteranalyst.com - December 16 at 9:04 PM

Social

What is Radius Health's stock symbol?

Radius Health trades on the NASDAQ under the ticker symbol "RDUS."

Where is Radius Health's stock going? Where will Radius Health's stock price be in 2017?

8 equities research analysts have issued 1-year target prices for Radius Health's shares. Their predictions range from $24.00 to $85.00. On average, they expect Radius Health's stock price to reach $57.57 in the next year.

When will Radius Health announce their earnings?

Radius Health is scheduled to release their next quarterly earnings announcement on Thursday, February, 23rd 2017.

What are analysts saying about Radius Health stock?

Here are some recent quotes from research analysts about Radius Health stock:

  • According to Zacks Investment Research, "Radius’ lead candidate abaloparatide for subcutaneous (abaloparatide-SC) injection is currently under review in both the U.S. and the EU. A response from the FDA is expected by Mar 30, 2017. An approval of the candidate will significantly boost the growth prospects of the company. However, its dependence on abaloparatide-SC is concerning, as the company has very few late-stage candidates in its pipeline. An unfavorable outcome from any regulatory body will adversely impact the stock. The company’ shares have underperformed the Zacks classified Medical-Drugs industry in the last twelve months. While the market for postmenopausal osteoporosis provides significant commercial potential, it is pretty crowded given the presence of products like Amgen’s Prolia and Lilly’s Forteo among others." (1/4/2017)

  • Cantor Fitzgerald analysts commented, "Filing Overhang to Recede. An NDA for abaloparatide-SC has been filed with FDA, following on the European validation of the MAA filing. This suggests to us that the U.S. PDUFA date will be early 2017. The U.S." (3/31/2016)

Who owns Radius Health stock?

Radius Health's stock is owned by a number of of retail and institutional investors. Top institutional investors include FMR LLC (15.00%), State Street Corp (4.37%), Franklin Resources Inc. (1.41%), Fiera Capital Corp (1.09%), Perceptive Advisors LLC (0.61%) and Oxford Asset Management (0.44%). Company insiders that own Radius Health stock include Gary Hattersley, Growth N V Biotech, Kurt Graves and Rob Ward.

Who sold Radius Health stock? Who is selling Radius Health stock?

Radius Health's stock was sold by a variety of institutional investors in the last quarter, including Fiera Capital Corp, Commerzbank Aktiengesellschaft FI, Franklin Resources Inc., Nicholas Investment Partners LP, AQR Capital Management LLC and Envestnet Asset Management Inc..

Who bought Radius Health stock? Who is buying Radius Health stock?

Radius Health's stock was bought by a variety of institutional investors in the last quarter, including State Street Corp, Perceptive Advisors LLC, Oxford Asset Management, Marshall Wace LLP, Folger Hill Asset Management LP, Russell Investments Group Ltd., FMR LLC and FNY Partners Fund LP.

How do I buy Radius Health stock?

Shares of Radius Health can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Radius Health stock cost?

One share of Radius Health stock can currently be purchased for approximately $42.48.

Radius Health (NASDAQ:RDUS) Chart for Thursday, February, 23, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Radius Health (NASDAQ:RDUS)

Earnings History Chart

Earnings by Quarter for Radius Health (NASDAQ:RDUS)

Dividend History Chart

Dividend Payments by Quarter for Radius Health (NASDAQ:RDUS)

Last Updated on 2/23/2017 by MarketBeat.com Staff